Shandong Sito Bio-technology Co., Ltd. (300583.SZ)
- Previous Close
13.28 - Open
12.78 - Bid 13.42 x --
- Ask 13.43 x --
- Day's Range
13.17 - 13.51 - 52 Week Range
11.94 - 23.84 - Volume
2,059,740 - Avg. Volume
2,756,499 - Market Cap (intraday)
2.551B - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
26.90 - EPS (TTM)
0.50 - Earnings Date --
- Forward Dividend & Yield 0.01 (0.07%)
- Ex-Dividend Date Jun 28, 2023
- 1y Target Est
--
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid biomedicine intermediates. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tetraene, androstenedione, ketal, 3-ketal, norandrostenedione, and betamethasone epoxy hydrolyzate, as well as 1,4-androstenedione. The company was founded in 2002 and is based in Heze, China.
www.sitobiotech.comRelated News
Performance Overview: 300583.SZ
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300583.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300583.SZ
Valuation Measures
Market Cap
2.52B
Enterprise Value
3.04B
Trailing P/E
26.36
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.38
Price/Book (mrq)
1.24
Enterprise Value/Revenue
2.33
Enterprise Value/EBITDA
29.99
Financial Highlights
Profitability and Income Statement
Profit Margin
4.75%
Return on Assets (ttm)
1.03%
Return on Equity (ttm)
3.66%
Revenue (ttm)
1.3B
Net Income Avi to Common (ttm)
61.83M
Diluted EPS (ttm)
0.50
Balance Sheet and Cash Flow
Total Cash (mrq)
284.58M
Total Debt/Equity (mrq)
40.52%
Levered Free Cash Flow (ttm)
-243.13M
Company Insights: 300583.SZ
300583.SZ does not have Company Insights